Please use this identifier to cite or link to this item:
Title: Increased Hb A2 values in an HIV-1-infected patient receiving antiretroviral drugs: A pitfall for thalassemia antenatal diagnosis
Authors: Sakorn Pornprasert
Kanyakan Sukunthamala
Pranee Leechanachai
Torpong Sanguansermsri
Keywords: Biochemistry, Genetics and Molecular Biology
Issue Date: 6-Jul-2009
Abstract: We report a human immunodeficiency virus-1 (HIV-1 )-infected couple, where the woman in the 11th week of gestation, carried a Hb E trait. She and her spouse were referred to tlie hemoglobinopathy counselors. Her spouse's blood was subsequently tested and showed an increased Hb A2value. However, his red cell indices and osmotic fragility test were different from those found in β-thalassemia β-thal) carriers. The β-thal genes were investigated further and no mutations were observed. Therefore, it is unlikely that he is a β-thal carrier and the increased Hb A2value is a result of receiving antirelroviral drugs. As antenatal thalassemia screening becomes more widespread, measuring the Hb A2values should be taken in all HIV-1-infected couples before the initiation of antiretroviral drugs to rule out misdiagnosis of β-thal. However, if these tests are not available, the results of the red cell indices and osmotic fragility test should be considered as they may provide great value for β-thal investigations.
ISSN: 1532432X
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.